A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery

Phase 4 Unknown 1300 enrolled The University of Hong Kong Queen Mary Hospital, Hong Kong · collab

RandomizedParallel-groupDouble-blindPrevention

Summary

The objective of the randomized controlled study is to compare combination of sublingual misoprostol and routine uterotonics versus routine uterotonics alone on PPH in low risk women after vaginal delivery. The hypothesis is that combination of sublingual misoprostol and routine uterotonics is more effective than routine uterotonics alone in reduction of PPH in low risk women after vaginal delivery.

Timeline

Start: 2022-04
Primary completion: 2024-06
Completion: 2024-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Misoprostol	Other / unclassified	600 ug	Other

Indications

No indication recorded.